ODI Medical is a leading brand specializing in the assessment of microcirculation using non-invasive technology. With a focus on improving healthcare outcomes, ODI Medical has developed a patented technology that allows for the assessment of microcirculation and oxygen delivery in patients with suspected or verified compromised respiratory or circulatory function. This innovative approach provides crucial insights to support clinical decision-making and optimize patient care.

Founded by Professor Knut Kvernebo, ODI Medical draws on 30 years of clinical research to provide cutting-edge solutions in the field. By assessing microcirculation, which plays a vital role in delivering oxygen to all living tissues, ODI Medical aids in the early detection and management of diseases that can cause changes in microcirculation. The impact of ODI technology is far-reaching, with leading cardiologists and gastroenterologists endorsing its potential to not only save patient morbidity but also reduce expensive care in intensive care units.

With a commitment to advancing healthcare, ODI Medical is revolutionizing the way microcirculation is assessed, ultimately improving patient outcomes and quality of care